Why DEA's latest move on telehealth could be a lifesaver

By AMA
| November 07, 2023

Physicians can continue to prescribe controlled substances based on telehealth patient visits after the DEA extended this regulatory flexibility through 2024.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...